Physician profile
Tom D Stanley
NPI 1710133210
$3,797.96
in general payments reported to CMS, 2019-2025
15 companies · $278 in 2025
The $278 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,343 · 2020: $304 · 2021: $115 · 2022: $103 · 2023: $380 · 2024: $275 · 2025: $278.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $933.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $2,530.73 | 2019-2023 | Acp, Tlif, Xlif |
| Globus Medical, INC. | $251.56 | 2024-2025 | Alif, Corridor, Tlif |
| Djo, LLC | $247.75 | 2019-2025 | Cmf |
| Si-Bone, INC. | $204.83 | 2019-2024 | |
| Surgenex LLC | $170.13 | 2025 | Ardeograft, Renograft, Surmatrix |
| Electronic Waveform Lab, INC. | $149.67 | 2020 | |
| Seaspine Orthopedics Corporation | $56.86 | 2020 | |
| Amgen INC. | $50.27 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $24.64 | 2020 | |
| Depuy Synthes Sales INC. | $24.44 | 2023 | Teligen |
| Oak Med, INC. | $20.29 | 2025 | |
| Genzyme Corporation | $19.91 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.40 | 2025 | |
| Janssen Biotech, INC. | $14.86 | 2022 | |
| Boston Scientific Corporation | $13.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tom Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.